These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2985303)

  • 1. Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case study.
    Hamblin PS; Mohr VS; Stockigt JR; Topliss DJ
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):503-10. PubMed ID: 2985303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients.
    Ramos-Dias JC; Lengyel AM
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):461-7. PubMed ID: 10583313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iopanoic acid as an adjunct to carbimazole in the management of hyperthyroidism.
    Gupta SK; Mithal A; Godbole MM
    Natl Med J India; 1992; 5(3):108-11. PubMed ID: 1304283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism.
    Bal C; Nair N
    J Nucl Med; 1990 Jul; 31(7):1180-2. PubMed ID: 2194004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis.
    Suzuki H; Kadena N; Takeuchi K; Nakagawa S
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):477-88. PubMed ID: 517049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.
    Larsen PR; Dick TE; Markovitz BP; Kaplan MM; Gard TG
    J Clin Invest; 1979 Jul; 64(1):117-28. PubMed ID: 447848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excessive peripheral conversion of thyroxine (T4) to triiodothyronine (T3) in the pathogenesis of T3-hyperthyroidism (author's transl)].
    Herrmann J; Lehr HJ; Kröll HJ; Rusche HJ; Rudorff KH; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Nov; 100(45):2319-23. PubMed ID: 52434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of iopanoic acid on thyroid hormone receptor, growth hormone production, and triiodothyronine generation from thyroxine in pituitary GH1 cells.
    Pascual A; Montiel F; Aranda A
    Endocrinology; 1987 Mar; 120(3):1089-96. PubMed ID: 3803311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of iopanoic acid for treatment of spontaneous hyperthyroidism in cats.
    Gallagher AE; Panciera DL
    J Feline Med Surg; 2011 Jun; 13(6):441-7. PubMed ID: 21515081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid.
    Dhillon KS; Cohan P; Kelly DF; Darwin CH; Iyer KV; Chopra IJ
    J Clin Endocrinol Metab; 2004 Feb; 89(2):708-11. PubMed ID: 14764785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism.
    Kasai K; Suzuki H; Shimoda SI
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):315-21. PubMed ID: 7376794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of iodine or iopanoic acid on thyroid Ca2+/NADPH-dependent H2O2-generating activity and thyroperoxidase in toxic diffuse goiters.
    Cardoso LC; Martins DC; Campos DV; Santos LM; Corrêa da Costa VM; Rosenthal D; Vaisman M; Violante AH; Carvalho DP
    Eur J Endocrinol; 2002 Sep; 147(3):293-8. PubMed ID: 12213665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term treatment of Graves' disease with iopanoic acid (Telepaque).
    Wang YS; Tsou CT; Lin WH; Hershman JM
    J Clin Endocrinol Metab; 1987 Oct; 65(4):679-82. PubMed ID: 3654913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simultaneously administered iopanoic acid and thyrotropin releasing hormone (TRH) on thyroid hormone metabolism in euthyroid subjects.
    Szabolcs I; Kovács Z; Góth M; Szilágyi G
    Exp Clin Endocrinol; 1988 Aug; 91(3):365-8. PubMed ID: 3150834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of some iodine-containing radiocontrast agents on iodothyronine secretion from the perfused canine thyroid.
    Laurberg P
    Endocrinology; 1982 Dec; 111(6):1904-8. PubMed ID: 7140639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are iodine-deficient rats euthyroid?
    Santisteban P; Obregon MJ; Rodriguez-Peña A; Lamas L; Del Rey FE; De Escobar GM
    Endocrinology; 1982 May; 110(5):1780-9. PubMed ID: 6804212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in thyroid function after cholecystographic contrast agents.
    Hunter AN; Meinhold H; Stockigt JR
    Aust N Z J Med; 1982 Apr; 12(2):192-5. PubMed ID: 6953963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
    Denereaz N; Lemarchand-Beraud T
    Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.